$ARLO earnings report

Record total revenue of $156 million, growing 21% year over year; record subscriptions and services revenue of $93 million, growing 19% year over year; GAAP net income of $3 million and record adjusted EBITDA of $31 million. AlphaAI read Arlo Technologies's Second Quarter 2026 filing as strong.

Second Quarter 2026

alphai · Earnings readARLO · Second Quarter 2026 · ended June 28, 2026

Record total revenue of $156 million, growing 21% year over year; record subscriptions and services revenue of $93 million, growing 19% year over year; GAAP net income of $3 million and record adjusted EBITDA of $31 million.

Strong quarter

Revenue, subscriptions and services revenue, gross margin, adjusted EBITDA, annual recurring revenue and paid accounts all reached or were reported at record or growing levels, while the company increased full-year total revenue and EPS guidance.

Revenue
$155,937
21% y/y
Subscriptions and services revenue
$93.0 million
growing 19.0% year over year y/y
Gross margin · GAAP
48.2%
growing 330 basis points year over year y/y
EPS · non-GAAP
$0.28
Third Quarter 2026 and Full Year 2026 outlook
GAAP and non-GAAP: $140 - $150 million (Third Quarter 2026); $580 - $600 million (Full Year 2026)

Key metrics

as reported
MetricValueq/qy/y
RevenueGAAP$155,93721%
RevenueGAAP$306,319
GAAP gross marginGAAP48.2%growing 330 basis points year over year
GAAP gross marginGAAP48.3%
Non-GAAP gross marginnon-GAAP50.6%growing 480 basis points year over year
Non-GAAP gross marginnon-GAAP50.3%
GAAP net incomeGAAP$3 million
Adjusted EBITDAnon-GAAP$30.6 millionup 70.3% year over year
Adjusted EBITDA marginnon-GAAP19.6%
GAAP EPS - dilutedGAAP$0.03
GAAP EPS - dilutedGAAP$0.16
Non-GAAP EPS - dilutednon-GAAP$0.28
Non-GAAP EPS - dilutednon-GAAP$0.56
Annual recurring revenue (ARR)other$365.0 milliongrowing 15.6% year over year
Cumulative paid accountsother6.3 milliongrowing 23.2% year over year
Free cash flow (FCF)other$33.9 million
FCF marginother11.1%
Cash and cash equivalents and short-term investmentsother$141.1 million
Tariff refund impactnon-GAAP$0.07

Segments

SegmentRevenueq/qy/y
Subscriptions and services revenueContinued strength in subscriptions and services revenue drove the top and bottom-line growth.$93.0 milliongrowing 19.0% year over year

Third Quarter 2026 and Full Year 2026 outlook

  • RevenueGAAP and non-GAAP: $140 - $150 million (Third Quarter 2026); $580 - $600 million (Full Year 2026)
  • NoteGAAP EPS - diluted: $(0.06) - $0.00 (Third Quarter 2026); $0.11 - $0.21 (Full Year 2026)
  • NoteAdjustments for stock-based compensation expense and others: $0.23 (Third Quarter 2026); $0.79 (Full Year 2026)
  • NoteNon-GAAP EPS - diluted: $0.17 - $0.23 (Third Quarter 2026); $0.90 - $1.00 (Full Year 2026)
  • NoteThe non-GAAP EPS outlook range above includes an expected tariff refund, all of which the company expects will be reinvested in growth initiatives to support its subscriptions and services business.

Capital returns

  • Repurchased $22 million of common stock during the second quarter, as part of the authorized stock repurchase program of $50 million.

What drove it

  • Continued strength in subscriptions and services revenue drove the top and bottom-line growth.
  • Subscriptions and services revenue accounted for 59.7% of total revenues.
  • GAAP subscriptions and services gross margin was 81.1% and non-GAAP subscriptions and services gross margin was 84.1%.
  • The company announced an expanded partnership between Aloe Care Health and Home Helpers Home Care to deploy a new AI-powered wellness service.

Concerns

  • The current global tariff environment is uncertain.
  • Products are manufactured outside the U.S., and tariffs increase product costs, which could impact sales and reduce product margin.
  • The company identified risks related to demand, consumer confidence, sales and marketing expansion, paid-subscription growth, product adoption, manufacturing and distribution, cost management, and integration of acquired businesses.

What to watch

  • Third Quarter 2026 revenue outlook of $140 - $150 million.
  • Third Quarter 2026 non-GAAP EPS - diluted outlook of $0.17 - $0.23.
  • Full Year 2026 revenue outlook of $580 - $600 million.
  • Full Year 2026 non-GAAP EPS - diluted outlook of $0.90 - $1.00.
  • Execution of growth initiatives supporting the subscriptions and services business that the company expects to fund with the expected tariff refund.

Balance sheet and cash flow

  • Free cash flow (FCF) of $33.9 million with FCF margin of 11.1% in the first half of 2026.
  • Cash and cash equivalents and short-term investments of $141.1 million, including the cash outflows for the acquisition of Aloe Care Health and stock repurchases.

Analysis

Arlo reported record second-quarter total revenue of $156 million, up 21% year over year. The financial table reported revenue of $155,937, compared with $129,405 in the prior-year quarter and $150,382 in the prior quarter. Subscriptions and services revenue reached a record $93.0 million, grew 19.0% year over year, and represented 59.7% of total revenues. ARR ended at $365.0 million, up 15.6% year over year, while cumulative paid accounts reached 6.3 million, up 23.2% year over year.

Margin results improved materially from the prior-year period. GAAP gross margin was 48.2%, compared with 44.9%, and non-GAAP gross margin was a record 50.6%, compared with 45.8%. The release attributed 330 basis points of year-over-year expansion to GAAP gross margin and 480 basis points to non-GAAP gross margin. Subscriptions and services gross margin was 81.1% on a GAAP basis and 84.1% on a non-GAAP basis, underscoring the higher-margin contribution from that revenue stream.

Profitability metrics included GAAP net income of $3 million, GAAP diluted EPS of $0.03, and non-GAAP diluted EPS of $0.28. Adjusted EBITDA was a record $30.6 million, up 70.3% year over year, with a 19.6% adjusted EBITDA margin. Non-GAAP EPS included a tariff refund impact of $0.07. For the first half of 2026, free cash flow was $33.9 million with an 11.1% FCF margin.

Capital allocation included $22 million of common-stock repurchases during the second quarter under the authorized $50 million stock repurchase program. Cash and cash equivalents and short-term investments were $141.1 million, including cash outflows for the Aloe Care Health acquisition and stock repurchases. The company also cited an expanded Aloe Care Health and Home Helpers Home Care partnership for an AI-powered wellness service.

Management raised annual guidance for total revenue and EPS. Third-quarter revenue guidance is $140 - $150 million, with GAAP diluted EPS of $(0.06) - $0.00 and non-GAAP diluted EPS of $0.17 - $0.23. Full-year revenue guidance is $580 - $600 million, with GAAP diluted EPS of $0.11 - $0.21 and non-GAAP diluted EPS of $0.90 - $1.00. The non-GAAP EPS outlook includes an expected tariff refund that the company expects to reinvest in subscriptions and services growth initiatives, while the filing identifies tariffs on products manufactured outside the U.S. as a potential pressure on product costs, sales and product margin.

Management, verbatim

We delivered outstanding financial results in the period with record total revenue of $156 million, up 21% year over year and record adjusted EBITDA of $31 million with EBITDA margin of 20%. Continued strength in subscriptions and services revenue drove the top and bottom-line growth, resulting in record levels of both consolidated non-GAAP gross margin and non-GAAP net income. As a result, we are increasing our annual guidance on both total revenue and EPS for the year.

Matthew McRae, Chief Executive Officer of Arlo Technologies

Not in the filing

stated, not guessed
  • GAAP operating income
  • Non-GAAP operating income
  • GAAP net income prior-year comparison
  • GAAP net income prior-quarter comparison
  • Operating cash flow
  • Capital expenditures
  • Debt balance
  • Dividend amount or dividend policy
  • Third Quarter 2026 gross margin guidance
  • Full Year 2026 gross margin guidance
  • Third Quarter 2026 operating-expense guidance
  • Full Year 2026 operating-expense guidance
  • Third Quarter 2026 tax-rate guidance
  • Full Year 2026 tax-rate guidance
  • Previous-release outlook for comparison with actual results

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about ARLO earnings dates

When is Arlo Technologies's next earnings date?
AlphaAI has no confirmed date for ARLO yet. We publish an earnings date only once the company has set it, so this page shows one the day that happens.
Where does the date come from, and why is there no estimate?
A confirmed date comes from the company's own announcement. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so AlphaAI shows nothing until the company confirms. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.
ARLO Earnings Date & Report — Arlo Technologies Results | alphai